×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMPX – compass therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMPX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/20
11:26 am
cmpx
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 [Seeking Alpha]
Neutral
Report
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 [Seeking Alpha]
1/19
05:06 pm
cmpx
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
1/16
09:38 pm
cmpx
Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]
Low
Report
Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]
1/16
03:41 am
cmpx
Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]
Low
Report
Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]
1/6
07:03 pm
cmpx
Compass Therapeutics Provides Corporate Update [Yahoo! Finance]
High
Report
Compass Therapeutics Provides Corporate Update [Yahoo! Finance]
1/6
02:14 pm
cmpx
Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/6
09:55 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Neutral
Report
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
08:00 am
cmpx
Form 4 Compass Therapeutics, For: Jan 09 Filed by: Schuetz Thomas J.
Medium
Report
Form 4 Compass Therapeutics, For: Jan 09 Filed by: Schuetz Thomas J.
1/8
06:02 am
cmpx
Form EFFECT Compass Therapeutics,
Medium
Report
Form EFFECT Compass Therapeutics,
1/6
08:01 am
cmpx
Form 8-K Compass Therapeutics, For: Jan 06
Medium
Report
Form 8-K Compass Therapeutics, For: Jan 06
1/5
04:34 pm
cmpx
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Sirard Cynthia
Low
Report
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Sirard Cynthia
1/5
04:34 pm
cmpx
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Schuetz Thomas J.
Low
Report
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Schuetz Thomas J.
1/5
04:34 pm
cmpx
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Shin Barry
Low
Report
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Shin Barry
1/5
04:33 pm
cmpx
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Lerner Neil
Low
Report
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Lerner Neil
1/5
04:33 pm
cmpx
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Prasad Arjun
Low
Report
Form 4 Compass Therapeutics, For: Jan 02 Filed by: Prasad Arjun
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: